210 related articles for article (PubMed ID: 32400219)
1. RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery.
Hao R; Sun B; Yang L; Ma C; Li S
Drug Deliv; 2020 Dec; 27(1):772-781. PubMed ID: 32400219
[TBL] [Abstract][Full Text] [Related]
2. Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia.
Li X; Li S; Ma C; Li T; Yang L
Drug Deliv; 2022 Dec; 29(1):1282-1298. PubMed ID: 35467483
[TBL] [Abstract][Full Text] [Related]
3. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
4. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles.
Chen W; Zhan C; Gu B; Meng Q; Wang H; Lu W; Hou H
J Drug Target; 2011 Apr; 19(3):228-34. PubMed ID: 20540685
[TBL] [Abstract][Full Text] [Related]
5. Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury.
Wang L; Xu L; Du J; Zhao X; Liu M; Feng J; Hu K
Drug Deliv; 2021 Dec; 28(1):1363-1375. PubMed ID: 34180761
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia.
Liu X; An C; Jin P; Liu X; Wang L
Biomaterials; 2013 Jan; 34(3):817-30. PubMed ID: 23111336
[TBL] [Abstract][Full Text] [Related]
8. A facile approach for synthesis of nano-CeO
Gao Y; Chen X; Liu H
J Photochem Photobiol B; 2018 Oct; 187():184-189. PubMed ID: 30173122
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia.
Piazza J; Hoare T; Molinaro L; Terpstra K; Bhandari J; Selvaganapathy PR; Gupta B; Mishra RK
Eur J Pharm Biopharm; 2014 May; 87(1):30-9. PubMed ID: 24560967
[TBL] [Abstract][Full Text] [Related]
10. Odorranalectin modified PEG-PLGA/PEG-PBLG curcumin-loaded nanoparticle for intranasal administration.
Li X; Su J; Kamal Z; Guo P; Wu X; Lu L; Wu H; Qiu M
Drug Dev Ind Pharm; 2020 Jun; 46(6):899-909. PubMed ID: 32375569
[TBL] [Abstract][Full Text] [Related]
11. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
Zhang C; Chen J; Feng C; Shao X; Liu Q; Zhang Q; Pang Z; Jiang X
Int J Pharm; 2014 Jan; 461(1-2):192-202. PubMed ID: 24300213
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas.
Kanazawa T; Taki H; Okada H
Eur J Pharm Biopharm; 2020 Jul; 152():85-94. PubMed ID: 32387702
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion Model.
Xiao XY; Zhu YX; Bu JY; Li GW; Zhou JH; Zhou SP
Biomed Res Int; 2016; 2016():2571060. PubMed ID: 27725936
[TBL] [Abstract][Full Text] [Related]
14. PEG-
Xu G; Gu H; Hu B; Tong F; Liu D; Yu X; Zheng Y; Gu J
Int J Nanomedicine; 2017; 12():2243-2254. PubMed ID: 28356740
[TBL] [Abstract][Full Text] [Related]
15. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
17. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
18. New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes.
Gao SJ; Liu Y; Wang HJ; Ban DX; Cheng SZ; Ning GZ; Wang LL; Chang J; Feng SQ
J Drug Target; 2017 Jan; 25(1):75-82. PubMed ID: 27250819
[TBL] [Abstract][Full Text] [Related]
19. Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study.
Gajbhiye KR; Gajbhiye V; Siddiqui IA; Pilla S; Soni V
Sci Rep; 2017 Sep; 7(1):11086. PubMed ID: 28894228
[TBL] [Abstract][Full Text] [Related]
20. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.
Zhang K; Tang X; Zhang J; Lu W; Lin X; Zhang Y; Tian B; Yang H; He H
J Control Release; 2014 Jun; 183():77-86. PubMed ID: 24675377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]